Frank R. Oakes, President & CEO at Stellar Biotechnologies, Inc. (SBOT), sold 4,000 shares at $1.25 ($5K) on 2019-03-06, disclosed to the SEC on 2019-03-11.
Scheduled sale ($5k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SBOT | SELL | 2018-10-12 | $4K | — | Filing → |